HRTX EPS Estimates
Heron Therapeutics, Inc.
$0.36
-$0.03(-7.32%)
49
Overall
40
Value
50
Tech
57
Quality
Market Cap
$74.16M
Volume
2.09M
52W Range
$0.26 - $1.58
Target Price
$2.00
HRTX EPS estimates: the consensus estimate for Heron Therapeutics, Inc.'s current fiscal year is -$0.14 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
HRTX EPS Estimates
- EPS estimate, current quarter
- $-0.03
- EPS estimate, next quarter
- $-0.03
- EPS estimate, current year
- $-0.14
- EPS estimate, next year
- $-0.12
- EPS growth, 3-year
- +58.43%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.12 |
| 2024 | $-0.09 |
| 2023 | $-0.80 |
| 2022 | $-1.67 |
| 2021 | $-2.24 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HRTX | $0.36 | -7.3% | 2.09M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Heron Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW